Federal Advocacy

 

LIPA works with lawmakers in the US Congress as well as organizations on the national level to ensure that the role of independent pharmacies not only survives, but thrives for years to come.

We are committed to progressively correcting the damaging influence exerted in the past decade by the uncontrolled expansion of PBMs. By working in Congress and the Legislature and supporting our national partners, we strive to assure that these entities are repositioned into a more appropriate role—that of supporting the needs of pharmaceutical distribution without being intrusive into the care of patients provided by licensed health care professionals.


 

Latest Federal Pharmacy Legislation
H.R. 244 - MAC Transparency Act of 2015

Summary: H.R. 244 is a bipartisan bill that would ensure federal health plan reimbursements to pharmacies keep pace with generic drug prices, many which skyrocket overnight. This bill would provide transparency and fairness to community pharmacies regarding their reimbursement for generic drugs. This bill would require pharmacy benefit managers (PBMs) to disclose the rate of reimbursement in the contract and to update that rate at least once every seven days to reflect fluctuations in the market.

  
S. 314 & H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act of 2015

Summary: Provider Status Legislation—these companion bills would recognize pharmacists as providers under the Medicare Part B program. If enacted, pharmacists would be able to perform services for patients consistent with their state’s scope of practice if their pharmacy is located in a medically underserved area, health professional shortage area, or medically underserved population.

S. 1190 & H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015

Summary: These companion bills would give independent pharmacies the ability to participate in preferred networks if one or more of their stores is located in a health professional shortage area, one or more of their stores is located in a medically underserved population, and if they can meet the terms and conditions that are offered to other in-network pharmacies.